NMPA Approval

Ranitidine Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20020275

Company广西裕源药业有限公司

Registration Date

September 29, 2020

Previous Approval Numbers

国药准字H20020275

Drug Information

Generic Name

盐酸雷尼替丁氯化钠注射液

Dosage Form

注射剂

Strength

250ml:雷尼替丁0.1g与氯化钠2.25g

Drug Type

化学药品

Registration Date

September 29, 2020

Company Information

Applicant Company

Company Name广西裕源药业有限公司

Company Address

广西浦北县城工业区

Manufacturing Company

Company Name广西裕源药业有限公司

Company Address

广西浦北县城工业区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁氯化钠注射液 - NMPA 批准文号 | MedPath